Compounding association to ask for clarity around tirzepatide’s shortage status

The Alliance for Pharmacy Compounding (APC) wants clarity around the FDA’s decision to reconsider tirzepatide’s removal from its national shortage list.

Compounders are allowed to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

FDA advisory panel overwhelmingly backs Abbott’s Triclip

Listen to the article 5 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: An advisory committee to the

February 14, 2024

Could reducing light exposure help you sleep better and improve your mental health during pregnancy?

Higher light exposure at night and poor sleep quality are associated with poorer mental health outcomes.

September 20, 2023

FDA: Don’t rush publishing your diversity guidance plan. Take your time and do it right

When Congress passed the Food and Drug Omnibus Reform Act (FDORA) in December 2022, it was hailed as a landmark step toward codifying diversity and

June 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.